Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
First Wave Bio (FWBI) has provided an announcement.
First Wave BioPharma, Inc. has engaged in a direct offering to sell shares and pre-funded warrants, expecting to raise approximately $3.6 million for working capital and general corporate purposes. The offering, priced at $7.61 per share and $7.6099 per warrant, includes additional warrants with each purchase, exercisable immediately with a five-year expiration. The company has stipulated a no-issue period for 60 days post-offering and a one-year restriction on variable rate transactions, with closing conditions expected to be satisfied around March 6, 2024.
For detailed information about FWBI stock, go to TipRanks’ Stock Analysis page.